CVS Health Corp (CVS) : Hudson Valley Investment Advisors Inc Adv scooped up 1,035 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 25, 2016. The investment management firm now holds a total of 66,928 shares of CVS Health Corp which is valued at $6,726,264.CVS Health Corp makes up approximately 2.17% of Hudson Valley Investment Advisors Inc Adv’s portfolio.
CVS Health Corp opened for trading at $100.5 and hit $101.93 on the upside on Monday, eventually ending the session at $101.45, with a gain of 0.95% or 0.95 points. The heightened volatility saw the trading volume jump to 54,86,259 shares. Company has a market cap of $111,442 M.
Other Hedge Funds, Including , Acropolis Investment Management reduced its stake in CVS by selling 1,260 shares or 15.49% in the most recent quarter. The Hedge Fund company now holds 6,875 shares of CVS which is valued at $690,938. CVS Health Corp makes up approx 0.13% of Acropolis Investment Management’s portfolio.Cohen Lawrence B boosted its stake in CVS in the latest quarter, The investment management firm added 3,215 additional shares and now holds a total of 50,553 shares of CVS Health Corp which is valued at $5,128,096. CVS Health Corp makes up approx 3.28% of Cohen Lawrence B’s portfolio.Sigma Planning Corp boosted its stake in CVS in the latest quarter, The investment management firm added 1,739 additional shares and now holds a total of 14,930 shares of CVS Health Corp which is valued at $1,514,499. CVS Health Corp makes up approx 0.20% of Sigma Planning Corp’s portfolio.Sit Investment Associates Inc reduced its stake in CVS by selling 17,325 shares or 2.2% in the most recent quarter. The Hedge Fund company now holds 771,890 shares of CVS which is valued at $78,918,034. CVS Health Corp makes up approx 1.43% of Sit Investment Associates Inc’s portfolio.Koshinski Asset Management boosted its stake in CVS in the latest quarter, The investment management firm added 530 additional shares and now holds a total of 3,505 shares of CVS Health Corp which is valued at $358,351. CVS Health Corp makes up approx 0.23% of Koshinski Asset Management’s portfolio.
On the company’s financial health, CVS Health Corp reported $1.53 EPS for the quarter, based on the information available during the earnings call on Feb 9, 2016. Analyst had a consensus estimate of $1.53. The company had revenue of $41145.00 million for the quarter, compared to analysts expectations of $41126.27 million. The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.21 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Shares were Reiterated by Mizuho on Feb 10, 2016 to “Buy” and Lowered the Price Target to $ 104 from a previous price target of $113 .CVS Health Corp was Initiated by Atlantic Equities to “Overweight” on Feb 3, 2016.
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.